News

Lonza and ABL Bio Collaborate on Bispecific Antibody Product

April 07, 2023

Lonza and ABL Bio are collaborating on the development and manufacture of bispecific antibody product.

NextPharma Acquires Chewable Tablets Manufacturing Site in Norway

April 07, 2023

NextPharma has acquired a leading European chewable tablets manufacturing site from Takeda in Asker, Norway.

Sartorius to Acquire Polyplus in $2.6 Billion Deal

April 05, 2023

Sartorius’ acquisition of Polyplus is designed to strengthen its cell and gene therapy capabilities.

Suppliers’ Supply Chains and Continuous Manufacturing Pose Big Risks for US CDMOs

April 04, 2023

A CPHI North America panel discussion forewarns that CDMO supply chains are potentially the biggest single risk to product resilience.

Zauberkugel: Pfizer’s Seagen Acquisition

April 02, 2023

What can we take away from Pfifzer's acquisition of Seagen?

Legislative Hold-Up

April 02, 2023

A further setback to the publication of the pharmaceutical legislative changes in Europe may mean time is running out for appropriate review before 2024 parliamentary elections.

Who’s Got Game?

April 02, 2023

Direct-to-consumer drug advertising has developed as a cottage industry which has been used to increase prescriptions immensely.

FDA Approves Evkeeza for Young Children with Ultra-Rare Form of High Cholesterol

March 31, 2023

FDA has approved Evkeeza for young children with homozygous familial hypercholesterolemia.

Takeda Gets Approval in Japan for Entyvio Subcutaneous Injection

March 30, 2023

Takeda received approval in Japan for a subcutaneous injection formulation of Entyvio (vedolizumab) for treating ulcerative colitis.

Exothera Partners with Remedium to Scale-Up Manufacturing of Gene Therapy Drug Candidate

March 30, 2023

CDMO Exothera and biotech company Remedium are joining forces to scale up the manufacturing process for Remedium’s lead gene therapy candidate for treating osteoarthritis.